Related Experiment Video
Updated: Jun 19, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
Published on: November 7, 2017
Association of race, heart failure and chronic kidney disease
Albert Yuh-Jer Shen1, Somjot S Brar, Steven S Khan
1Division of Cardiology, Department of Medicine, Kaiser Permanente Los Angeles Medical Center, 1526 North Edgemont Street, Los Angeles, CA 90027, USA. albert.y-j.shen@kp.org
Insights
Heart failure and kidney disease are growing epidemics affecting many adults. Racial disparities exist in disease causes and treatment responses, necessitating inclusive research.
Area of Science:
- Cardiology
- Nephrology
- Public Health
- Health Disparities
Background:
- Heart failure and kidney disease are significant, growing public health concerns.
- Approximately 50% of heart failure patients have co-existing kidney disease.
- Racial and ethnic groups exhibit different primary causes for these conditions, including hypertension, ischemic heart disease, and diabetic kidney disease.
Purpose of the Study:
- To highlight the prevalence and co-occurrence of heart failure and kidney disease.
- To examine racial and ethnic variations in the etiologies of these diseases.
- To underscore the need for research that addresses racial differences in disease burden and treatment response.
Main Methods:
- Review of existing epidemiological data and clinical guidelines.
- Analysis of disease distribution across different racial and ethnic populations.
- Synthesis of current understanding regarding racial variations in therapeutic responses.
Main Results:
- One in nine US adults has kidney disease, with a high comorbidity with heart failure.
- Hypertension is a major cause in Black populations, ischemic heart disease in Whites, and diabetic kidney disease in Hispanics.
- Minority populations disproportionately bear the burden of these diseases.
- Emerging evidence suggests racial differences in drug responsiveness.
Conclusions:
- The co-occurrence of heart failure and kidney disease presents a substantial public health challenge.
- Understanding and addressing racial and ethnic disparities in disease etiology and outcomes is critical.
- Future research must incorporate diverse populations to elucidate and account for racial differences in disease progression and treatment efficacy.
Abstract:
Heart failure and kidney disease are two important emerging epidemics. The importance of pre-end stage kidney disease was introduced in the 2002 publication of the National Kidney Foundation's Chronic Kidney Disease Guidelines. One in nine US adults has some degree of kidney disease, many of whom also have heart failure. Among all patients with heart failure, approximately half have significant kidney disease. The distribution of etiologies of these conditions varies among races; blacks tend to have heart and kidney disease predominantly due to hypertension, while whites tend to be affected by ischemic heart disease and Hispanics by diabetic kidney disease. The burden of disease is disproportionately borne by minorities, the cause of which remains to be fully elucidated. The bulk of knowledge of these diseases is based on studies involving predominantly white subjects. Recent studies have suggested that there are racial differences in patients' responsiveness to various classes of drugs. Designs of future studies should take into account these differences.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Pathophysiology of Heart Failure
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management
Heart Failure Drugs: Diuretics
